Page last updated: 2024-11-07

metaraminol and Subarachnoid Hemorrhage

metaraminol has been researched along with Subarachnoid Hemorrhage in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SPOEREL, WE1
SELENY, FL1
WILLIAMSON, RD1

Other Studies

1 other study available for metaraminol and Subarachnoid Hemorrhage

ArticleYear
SHOCK CAUSED BY CONTINUOUS INFUSION OF METARAMINOL BITARTRATE (ARAMINE).
    Canadian Medical Association journal, 1964, Feb-01, Volume: 90

    Topics: Asthma; Blood Pressure; Blood Pressure Determination; Bronchitis; Geriatrics; Hemorrhoids; Humans; H

1964